Edesa Biotech
EDSA
11 hedge funds and large institutions have $90K invested in Edesa Biotech in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
365% more capital inflows, than outflows
Capital inflows: $111K | Capital outflows: $23.9K
22% more funds holding
Funds holding: 9 → 11 (+2)
0.76% more ownership
Funds ownership: 0.31% → 1.07% (+0.76%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$53.8K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$51.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Advisor Group
Phoenix,
Arizona
|
-$23.6K |
| 2 |
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$318 |
EDSA Hedge Fund Activity: Q4 2017 in Review
11 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2017, worth a combined $90K — up 150% from $36K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new EDSA positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $53.8K. The largest seller was Advisor Group, cutting an estimated $23.6K.
- 11 institutional investors held Edesa Biotech (EDSA) as of Q4 2017, up from 9 in Q3 2017.
- Funds reported $90K of Edesa Biotech stock for Q4 2017, up 150% quarter-over-quarter.
- 2 funds opened new Edesa Biotech positions in Q4 2017 and 0 closed out, a net change of +2 holders.
- The largest Edesa Biotech buyer in Q4 2017 was Renaissance Technologies, an estimated $53.8K added.
- The largest Edesa Biotech seller in Q4 2017 was Advisor Group, an estimated $23.6K sold.
Based on aggregated 13F filings for Q4 2017.